The ACME Laboratories Ltd. (DSE:ACMELAB)
Bangladesh · Delayed Price · Currency is BDT 79.10
0.00 (0.00%)
At close: Sep 3, 2026
The ACME Laboratories Market Cap
The ACME Laboratories has a market cap or net worth of 16.74 billion as of September 4, 2026. Its market cap has decreased by -4.70% in one year.
Market Cap
16.74B
Enterprise Value
36.69B
Revenue
40.05B
Ranking
n/a
PE Ratio
6.28
Stock Price
79.10
ChartMarket Cap Chart
Since June 8, 2016, The ACME Laboratories's market cap has decreased from 23.61B to 16.74B, a decrease of -29.12%. That is a compound annual growth rate of -3.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 16.74B | 11.57% |
| Dec 30, 2025 | 15.00B | -5.59% |
| Dec 30, 2024 | 15.89B | -11.65% |
| Dec 28, 2023 | 17.99B | - |
| Dec 29, 2022 | 17.99B | -1.73% |
| Dec 30, 2021 | 18.30B | 15.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Renata | 53.15B |
| Unilever Consumer Care | 38.52B |
| Beacon Pharmaceuticals | 24.37B |
| Asiatic Laboratories | 13.45B |
| The IBN SINA Pharmaceutical Industry | 9.76B |
| Navana Pharmaceuticals | 7.13B |
| Orion Pharma | 6.13B |
| Techno Drugs | 5.66B |